Remove 2019 Remove Financial Market Remove License
article thumbnail

Titagarh Railsystems vs Jupiter Wagons – Future Plans & More

Trade Brains

Particulars/ Financial Year Revenue (Cr.) 2019-20 ₹ 1,766.32 ₹ 125.74 2019-20 ₹ - 36.14 -₹ 0.13 Particulars/ Financial Year Debt to Equity Titagarh Railsystems Jupiter Wagons 2022-23 0.71 Particulars/ Financial Year Interest Coverage Titagarh Railsystems Jupiter Wagons 2022-23 3.24 2019-20 0.36 -0.48

Planning 105
article thumbnail

Fundamental Analysis of Bajaj Consumer Care – Financials & More

Trade Brains

The company turned into a subsidiary of Bajaj Resources in 2008, licensing its brand to itself. In 2019, the company renamed itself to what we know today – Bajaj Consumer Care. In CR) FY 2019 918 30.9% 139 Bajaj Consumer Care is a small-cap FMCG stock, with a market capitalization of ₹2,491 crores. FY 2020 28.28

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Fundamental Analysis of Ujjivan Small Finance Bank

Trade Brains

It is licensed under the Banking Regulation Act, to carry out small finance bank business. Ujjivan Financial Services is its Parent Company holding an 80 percent stake in the bank. Then we will look at the return generated by the Bank towards its shareholders, before finally reaching a conclusion. These deposits grew by ~40%, from Rs.

Banking 126
article thumbnail

From Hard Landing to Soft Landing to No Landing?

Investing Caffeine

I haven’t received my pilot’s license yet, but in trying to figure out whether the economy is heading for a hard landing, soft landing, or no landing, I’m planning to enroll in flight school soon! With the Federal Reserve approaching the tail end of an aggressive interest rate hiking cycle, investors have been bracing for a hard landing.

Economy 59
article thumbnail

Everything you need to know about NSE IPO

Trade Brains

Growth potential: With a solid growth history, NSE is well-positioned to capitalize on India’s expanding economy, which promises significant opportunities for further financial market expansion. Regulatory approvals: NSE’s business heavily relies on obtaining and renewing statutory approvals, licenses, and permissions.

article thumbnail

Cipla Vs Dr. Reddy’s Laboratories – Financials, Future Plans & More

Trade Brains

Particulars / Fiscal Year 2019 2020 2021 2022 2023 5 Year CAGR Cipla - Revenue ₹16,362.00 ₹17,132.00 ₹19,160.00 ₹21,763.00 ₹22,753.00 Particulars / Fiscal Year 2019 2020 2021 2022 2023 5 Year Avg Cipla - Debt to Equity 0.29 Profitability of Cipla & Dr. Reddy’s grew by 16% and 23% on a 5 Year CAGR. respectively. respectively.

article thumbnail

Fundamental Analysis of Varun Beverages – Financials & More Details

Trade Brains

The company entered into a bottling and trademark licensing agreement with PepsiCo to sell carbonated beverages in India. Fiscal Year Operating Revenue Net Proft 2022 13,391 1,550 2021 8,958 746 2020 6,556 357 2019 7,248 472 2018 5,228 300 5-Yr CAGR 20.7% 2019 3,359 14.1 Company Overview Varun Beverages Ltd. 2021 4,197 17.8

Sales 52